Dupliumab therapy for alopecia areata: a case series and review of the literature

CONCLUSIONS: Overall, our research supports dupilumab as another candidate that possesses potential benefits for AA. High levels of IgE may be not prerequisites for dupilumab's successful treatment response.PMID:38342501 | DOI:10.1080/09546634.2024.2312245
Source: Journal of Dermatological Treatment - Category: Dermatology Authors: Source Type: research